Literature DB >> 2332431

Localization of the diphtheria toxin receptor-binding domain to the carboxyl-terminal Mr approximately 6000 region of the toxin.

J M Rolf1, H M Gaudin, L Eidels.   

Abstract

The carboxyl-terminal Mr = 5982 peptide of diphtheria toxin was prepared by specific cleavage of the toxin with hydroxylamine and purified by fast performance liquid chromatography. The identity of the peptide was established by a combination of sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis, reactivity with specific monoclonal antibodies, and amino-terminal sequence analysis. The Mr = 5982 peptide was shown to protect highly toxin-sensitive Vero cells from the lethal action of diphtheria toxin. This protection was shown to be due to inhibition of the initial step in the cytotoxic process, the binding of toxin to its receptor. These results strongly suggest that the Mr = 5982 carboxyl-terminal region (amino acid residues 482-535) is, or contains, the receptor-binding domain of diphtheria toxin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2332431

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Isolation of a human monoclonal antibody with strong neutralizing activity against diphtheria toxin.

Authors:  Mai Kakita; Tsuyoshi Takahashi; Takako Komiya; Yoshitaka Iba; Takao Tsuji; Yoshikazu Kurosawa; Motohide Takahashi
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 2.  Immunotoxins for targeted cancer therapy.

Authors:  Robert J Kreitman
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

3.  Structure-function analyses of diphtheria toxin by use of monoclonal antibodies.

Authors:  J M Rolf; L Eidels
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

4.  Subcloning and characterization of the binding domain of fragment B of diphtheria toxin.

Authors:  Q Y Esbensen; P O Falnes; S Olsnes; I H Madshus
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

5.  Recombinant Staphylococcus strains as live vectors for the induction of neutralizing anti-diphtheria toxin antisera.

Authors:  C Fromen-Romano; P Drevet; A Robert; A Ménez; M Léonetti
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

6.  Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder.

Authors:  M R Freeman; J J Yoo; G Raab; S Soker; R M Adam; F X Schneck; A A Renshaw; M Klagsbrun; A Atala
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

7.  Towards a recombinant vaccine against diphtheria toxin.

Authors:  K Lobeck; P Drevet; M Léonetti; C Fromen-Romano; F Ducancel; E Lajeunesse; C Lemaire; A Ménez
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

8.  Expression of functional diphtheria toxin receptors on highly toxin-sensitive mouse cells that specifically bind radioiodinated toxin.

Authors:  J G Naglich; J M Rolf; L Eidels
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 9.  Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.

Authors:  Robert J Kreitman
Journal:  BioDrugs       Date:  2009       Impact factor: 5.807

10.  Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).

Authors:  J K Batra; D J Fitzgerald; V K Chaudhary; I Pastan
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 5.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.